American Journal of Ophthalmology
Volume 147, Issue 2 , Pages 234-238.e1, February 2009

Liquid Nitrogen Cryotherapy of Superior Limbic Keratoconjunctivitis

  • Frederick W. Fraunfelder

      Affiliations

    • Corresponding Author InformationInquiries to Frederick W. Fraunfelder, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239

Casey Eye Institute, Oregon Health & Science University, Portland, Oregon

Accepted 31 July 2008. published online 06 October 2008.

Purpose

To evaluate the effects of liquid nitrogen cryotherapy on superior limbic keratoconjunctivitis (SLK).

Design

Interventional case series.

Methods

In this clinical practice case series, the effects of liquid nitrogen cryotherapy on SLK were observed. Liquid nitrogen cryotherapy was performed using a Brymill E tip spray (0.013-inch aperture) with a double freeze-thaw technique. All subjects were outpatients who had local anesthesia with a single drop of topical proparacaine. The main outcome measure was the resolution of the disease process after treatment.

Results

Four female patients (average age, 64 ± 13 years) and seven eyes with SLK were treated with liquid nitrogen cryotherapy. Resolution of signs and symptoms occurred within two weeks. Disease recurred in two patients and three of seven eyes, although repeat cryotherapy eradicated SLK in all cases. The repeat cryotherapy was performed at three months postoperatively. There were no adverse ocular events.

Conclusions

Liquid nitrogen cryotherapy appears to be an effective alternative treatment for SLK as all subjects studied achieved long-term cures. Repeat cryotherapy may be necessary in some instances and may be performed three months after the first treatment.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9394(08)00616-8

doi:10.1016/j.ajo.2008.07.047

American Journal of Ophthalmology
Volume 147, Issue 2 , Pages 234-238.e1, February 2009